the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon

Patients often don't realize the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon.

This applies to the many patients with cardiovascular disease on aspirin to prevent a recurrent event...or on aspirin plus clopidogrel for acute coronary syndrome or after a stent.

Stopping these too soon can be catastrophic.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote